95 results on '"Cotter, David"'
Search Results
2. Functional impairment of cortical AMPA receptors in schizophrenia
3. Plasma lipid alterations in young adults with psychotic experiences: A study from the Avon Longitudinal Study of Parents and Children cohort
4. Peripheral complement proteins in schizophrenia: A systematic review and meta-analysis of serological studies
5. ApoE elevation is associated with the persistence of psychotic experiences from age 12 to age 18: Evidence from the ALSPAC birth cohort
6. A systematic review of metabolite biomarkers of schizophrenia
7. Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis – Results of the randomized controlled Vienna omega-3 study
8. Proteomic pathway analysis of the hippocampus in schizophrenia and bipolar affective disorder implicates 14-3-3 signaling, aryl hydrocarbon receptor signaling, and glucose metabolism: Potential roles in GABAergic interneuron pathology
9. Evidence of female-specific glial deficits in the hippocampus in a mouse model of prenatal stress
10. Two-dimensional assessment of cytoarchitecture in the superior temporal white matter in schizophrenia, major depressive disorder and bipolar disorder
11. Evidence for altered neuronal organisation within the planum temporale in major psychiatric disorders
12. Occupational gender segregation and the earnings gap: changes in the 1980s
13. An investigation of the Wnt-signalling pathway in the prefrontal cortex in schizophrenia, bipolar disorder and major depressive disorder
14. Is reduced dermatoglyphic a–b ridge count a reliable marker of developmental impairment in schizophrenia?
15. Increased dendritic MAP2 expression in the hippocampus in schizophrenia
16. Focal cortical dysplasia: a neuropathological and developmental perspective
17. Mamillary body abnormalities in schizophrenia
18. Poster #T144 INTEGRATED GENOMIC AND PROTEOMIC EVIDENCE FOR THE POSTSYNAPTIC DENSITY IN SCHIZOPHRENIA
19. Poster #T75 PRENATAL EXPOSURE TO MATERNAL IMMUNE STIMULATION LEADS TO CHANGES IN MYELIN PROTEINS IN THE ADULT RAT PREFRONTAL CORTEX WHICH CAN BE PREVENTED BY RISPERIDONE IN ADOLESENCE
20. Poster #T31 PROTEOMIC INVESTIGATION AND CHARACTERISATION OF POST-TRANSLATIONAL MODIFICATIONS OF HISTONE PROTEINS PURIFIED FROM PRENATALLY STRESSED MOUSE BRAIN TISSUE
21. Poster #M114 SHARED RISK FACTORS BETWEEN SCHIZOPHRENIA AND OTHER NEURODEVELOPMENTAL DISORDERS
22. Poster #S177 PROTEOMIC AND GENOMIC ANALYSES IMPLICATE THE POSTSYNAPTIC DENSITY IN SCHIZOPHRENIA
23. SIGNIFICANT DOWN-REGULATION OF EIF2 AND ASSOCIATED RIBOSOMAL PROTEINS IN ONS CELL MODEL OF SCHIZOPHRENIA
24. MODELING SCHIZOPHRENIA USING PATIENT DERIVED CELLS – BUT WHICH ONES?
25. Impact of Peripheral Ketolytic Deficiency on Hepatic Ketogenesis and Gluconeogenesis during the Transition to Birth.
26. Obligate Role for Ketone Body Oxidation in Neonatal Metabolic Homeostasis.
27. Poster #132 PROTEOMIC INVESTIGATION OF THE POSTSYNAPTIC DENSITY IN THE BRAIN IN SCHIZOPHRENIA
28. Poster #179 PROTEOMIC ANALYSIS OF THE CORPUS CALLOSUM REVEALS DOWN-REGULATION OF THE GLYCOLYSIS PROTEIN PATHWAY AND FURTHER IMPLICATES CME IN SCHIZOPHRENIA
29. Poster #135 MYELIN PATHOLOGYAND ITS RELATIONSHIP TO IRON HOMEOSTASISIN SCHIZOPHRENIA
30. CLATHRIN-MEDIATED-ENDOCYTOSIS AND CLATHRIN-DEPENDENT MEMBRANE AND PROTEIN TRAFFICKING; CORE PATHOPHYSIOLOGICAL PROCESSES IN SCHIZOPHRENIA AND BIPOLAR DISORDER?
31. The density and spatial distribution of gabaergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia
32. DIFFERENTIAL EFFECTS OF CHRONIC ADOLESCENT VS. ADULT THC EXPOSURE IN COMT KNOCKOUT MICE ON PHENOTYPES RELEVANT TO PSYCHOSIS
33. PROTEOMIC ANALYSIS OF THE BASIC SUB-PROTEOME (PH 6-11) IN THE HIPPOCAMPUS IN SCHIZOPHRENIA AND BIPOLAR AFFECTIVE DISORDER
34. PROTEOMIC ANALYSIS OF HIPPOCAMPAL SUB-REGIONS IN SCHIZOPHRENIA AND BIPOLAR DISORDER REVEALS MOST PROMINENT CHANGES IN CA2/3 AND IMPLICATES ABNORMALITIES IN CLATHRIN MEDIATED ENDOCYTOSIS
35. IS TRAUMATIC BRAIN INJURY A RISK FACTOR FOR PSYCHOSIS? A SYSTEMATIC REVIEW AND META-ANALYSIS
36. WHAT PROTEOMICS WILL ADD TO OUR UNDERSTANDING OF THE NEUROPATHOLOGY OF SCHIZOPHRENIA
37. PROTEOMIC AND WESTERN BLOT ANALYSIS OF HIPPOCAMPAL SUBREGIONS IN SCHIZOPHRENIA AND BIPOLAR DISORDER
38. EVIDENCE FOR CYTOSKELETAL ABNORMALITIES IN WHITE MATTER FROM SUBJECTS WITH SCHIZOPHRENIA AND BIPOLAR DISORDER
39. Glial cell number and nuclear size in the mediodorsal thalamic nucleus (MDNT) in schizophrenia
40. Neuropathology of mood disorders.
41. Emerging therapies for atopic dermatitis: JAK inhibitors.
42. Tunable narrow-band coherent VUV source for the lyman-alpha region
43. A tunable picosecond IR laser generating multi-megawatt pulses in the range 3–8 m
44. Stimulated multipole Raman scattering between opposite-parity states of atomic potassium
45. Picosecond pulse generation in the infrared by stimulated Raman scattering in atomic vapours
46. Further evidence for anomalies in the hand-prints of patients with schizophrenia: a study of secondary creases
47. Does prenatal exposure to influenza in mice induce pyramidal cell disarray in the dorsal hippocampus?
48. The MADS-box transcription factor SrfA is required for actin cytoskeleton organization and spore coat stability during Dictyostelium sporulation
49. Integrated Lipidomics and Proteomics Point to Early Blood-Based Changes in Childhood Preceding Later Development of Psychotic Experiences: Evidence From the Avon Longitudinal Study of Parents and Children.
50. 120 Differential complement activation in the blood of individuals at clinical high risk for psychosis compared with healthy controls.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.